{"id":"gb001-recombinant-peptide-spray","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reactions"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201718","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"GB001 works by mimicking a natural peptide in the body, which helps to regulate a specific biological process. This process is disrupted in individuals with the targeted disease, leading to the development of symptoms. By replacing the deficient peptide, GB001 aims to restore normal biological function and alleviate symptoms.","oneSentence":"GB001 recombinant peptide spray is a recombinant peptide that targets the underlying cause of a specific disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:00:55.261Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT06429566","phase":"PHASE2","title":"Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zhejiang Echon Biopharm Limited","startDate":"2023-07-18","conditions":"Healthy","enrollment":120},{"nctId":"NCT05125211","phase":"PHASE1","title":"Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zhejiang Echon Biopharm Limited","startDate":"2022-08-08","conditions":"Healthy","enrollment":91}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GB001 recombinant peptide spray","genericName":"GB001 recombinant peptide spray","companyName":"Zhejiang Echon Biopharm Limited","companyId":"zhejiang-echon-biopharm-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GB001 recombinant peptide spray is a recombinant peptide that targets the underlying cause of a specific disease. Used for Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}